The incoming Trump administration’s plans for new US Food and Drug Administration initiatives are more likely to succeed if they flow from ideas generated by agency staff and are supported by the center directors, current and former agency leaders said.
Trump’s US FDA Reforms Need Center Director, Staff Support To Succeed, Former Leaders Say
Former FDA commissioners Mark McClellan and Scott Gottlieb, former acting commissioner Janet Woodcock and current commissioner Robert Califf offered advice on successfully implementing reforms and preventing a mass exodus of FDA employees as inklings emerge that the Trump team is already engaged on this front.
